Brooks Laboratories Limited — QIP/Rights/Pref., 18-12-2024: Preferential issue

The Fund Raising Committee has approved a preferential issue for up to 35,33,520 equity shares with a face value of Rs. 10 each at an issue price of Rs. 141.50 per share, aggregating up to Rs. 49.99 crore. The issue is aimed at raising funds and is subject to shareholder approval in an upcoming Extraordinary General Meeting. The preferential allotment will include notable investors such as Quant Mutual Fund and other prominent participants, reflecting strong interest in the offering.